Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Scott Munk

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
BMC Public Health|April 4, 2018
EX-MET study: exercise in prevention on of metabolic syndrome - a randomized multicenter trial: rational and designArnt Erik Tjønna, Joyce S Ramos, Axel Pressler, et al.
Cardiology|June 27, 2017
Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase ProteinsNoreen Butt, Lena K Bache-Mathiesen, Jan Erik Nordrehaug, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
BMC Public Health|April 4, 2018
EX-MET study: exercise in prevention on of metabolic syndrome - a randomized multicenter trial: rational and designArnt Erik Tjønna, Joyce S Ramos, Axel Pressler, et al.
Cardiology|June 27, 2017
Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase ProteinsNoreen Butt, Lena K Bache-Mathiesen, Jan Erik Nordrehaug, et al.
Pageof 3